Recurrent UTI in Women-Risk Factors and Management
- PMID: 38599896
- DOI: 10.1016/j.idc.2024.03.010
Recurrent UTI in Women-Risk Factors and Management
Abstract
Urinary tract infections (UTIs) are common in women; more than 50% of women will be diagnosed with a UTI in her lifetime. Many of these women will go on to develop recurrent UTI. Nevertheless, evidence-based prevention of recurrent UTI is under-utilized. Here, the authors provide detailed practical advice on UTI prevention with a thorough review of the evidence. Non-antibiotic prevention measures discussed include increased fluid intake, vaginal estrogen therapy, methenamine, and cranberry. Antibiotic prophyalxis for carefully selected patients is also discussed.
Keywords: Methenamine; Recurrent urinary tract infection; Urinary tract infection; Vaginal estrogen.
Published by Elsevier Inc.
Conflict of interest statement
Disclosure J.E. Lazarus has served as a consultant for LUCA Biologics in the past. K. Gupta has served as a consultant for GSK, Iterum Therapeutics, Utility Therapeutics, Qiagen Diagnostics on UTI topics, recieves royalties from UpToDate on UTI topics; and is an uncompensated co-author of the IDSA Guidelines on UTI.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
